Have a personal or library account? Click to login
The Risk/Benefit Analysis of Oral Anticoagulant Treatment in Atrial Fibrillation Using HAS-BLED and CHA2DS2-VASc Score Cover

The Risk/Benefit Analysis of Oral Anticoagulant Treatment in Atrial Fibrillation Using HAS-BLED and CHA2DS2-VASc Score

Acta Marisiensis - Seria Medica
Volume 61 (2015): Issue 4 (December 2015)
By: Silivastru (Cozlea) Ionela,  Cozlea Daniel Laurentiu,  Keresztesi Arthur Attila,  Asofie Gabriela,  Cozlea Laurentiu,  Oltean Galafteon and  Dobru Daniela  
Open Access
|Jan 2016

References

  1. 1. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation). Circulation. 2001;104: 2118-2150.10.1161/circ.104.17.2118
    Search in Google Scholar
  2. 2. Guidelines for the management of atrial fibrillation. European Heart Journal. 2010;31: 2369–2429.10.1093/eurheartj/ehq27820802247
    Search in Google Scholar
  3. 3. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Annals of Internal Medicine. 2007;146: 857-867.10.7326/0003-4819-146-12-200706190-0000717577005
    Search in Google Scholar
  4. 4. Camm AJ, Lip GY, De Caterina R et al. Focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. European Heart Journal. 2012;33:2719-2747.
    Search in Google Scholar
  5. 5. Pisters R, Lane DA, de Vos CB et al. A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey. Chest. 2010;138(5):1093-1100.10.1378/chest.10-013420299623
    Search in Google Scholar
  6. 6. Thrift AG, Donnan GA, Mc Neil JJ. Epidemiology of intracranial hemorrhage. Epidemiologic Reviews. 1995;17:361-381.10.1093/oxfordjournals.epirev.a0361998654517
    Search in Google Scholar
  7. 7. Kase CS. Intracerebral hemorrhage. Baillière’s Clinical Neurology. 1995;4:247-278.
    Search in Google Scholar
  8. 8. Shorr RL, Ray WA, Daugherty JR et al. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk of hemorrhagic peptic ulcer disease. Annals of Internal Medicine. 1993;153:1665-1670.10.1001/archinte.1993.00410140047006
    Search in Google Scholar
  9. 9. Eva Prescott, Rikke Sørensen. Female sex as a risk factor for stroke in atrial fibrillation. British Medical Journal. 2012;344:e3789.10.1136/bmj.e378922653983
    Search in Google Scholar
  10. 10. Avgil TM, Jackevicius CA, Rahme E et al. Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation. The Journal of the American Medical Association. 2012;307:1952-1958.10.1001/jama.2012.349022570463
    Search in Google Scholar
  11. 11. Dagres N, Nieuwlaat R, Vardas PE et al. Gender-related differences in presentation, treatment and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. Journal of the American College of Cardiology. 2007; 49:572-577.10.1016/j.jacc.2006.10.04717276181
    Search in Google Scholar
  12. 12. Flaherty MLKB, Woo D, Kleindorfer D et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology. 2007;68:116-121.10.1212/01.wnl.0000250340.05202.8b17210891
    Search in Google Scholar
  13. 13. Geraint Fuller, Mark Manford. Neurology: An illustrated colour text, Churchill Livingstone Elsevier. Philadelphia. 2006;70-71.
    Search in Google Scholar
  14. 14. Sacco RL, Foulkes MA, Mohr JP et al. Determinants of early recurrence of cerebral infarction: the Stroke Data Bank. Stroke. 1989;20:983-989.10.1161/01.STR.20.8.983
    Search in Google Scholar
  15. 15. Sacco RL, Shi T, Zamanillo MC et al. Predictors of mortality and recurrence after hospitalised cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology. 1994;44:626-634.10.1212/WNL.44.4.626
    Search in Google Scholar
  16. 16. Hallas J, Dall M, Andersen BS et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. British Medical Journal. 2006;333:726.10.1136/bmj.38947.697558.AE
    Search in Google Scholar
  17. 17. Sørensen R, Hansen ML, Abildstrom SZ et al. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. The Lancet. 2009;374:1967-1974.10.1016/S0140-6736(09)61751-7
    Search in Google Scholar
  18. 18. Saour JN, Sieck JO, Mamo LA et al. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. New England Journal of Medicine. 1990;322:428-432.10.1056/NEJM199002153220703
    Search in Google Scholar
  19. 19. Palareti G, Leali N, Coccheri S et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. The Lancet. 1996;348:423-428.10.1016/S0140-6736(96)01109-9
    Search in Google Scholar
  20. 20. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Annals of Internal Medicine. 1994;120:897-902.10.7326/0003-4819-120-11-199406010-000018172435
    Search in Google Scholar
DOI: https://doi.org/10.1515/amma-2015-0056 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Journal RSS Feed
Language: English
Page range: 269 - 272
Submitted on: Dec 9, 2014
|
Accepted on: Jun 4, 2015
|
Published on: Jan 19, 2016
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
atrial fibrillation,
thromboembolic events,
bleeding events,
oral anticoagulant treatment
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2016 Silivastru (Cozlea) Ionela, Cozlea Daniel Laurentiu, Keresztesi Arthur Attila, Asofie Gabriela, Cozlea Laurentiu, Oltean Galafteon, Dobru Daniela, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 61 (2015): Issue 4 (December 2015)Next article